[{"address1": "910 Clopper Road", "address2": "Suite 201S", "city": "Gaithersburg", "state": "MD", "zip": "20878", "country": "United States", "phone": "240 654 1450", "website": "https://altimmune.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide, a GLP-1/glucagon dual receptor agonist that is in Phase 2 trial for the treatment of obesity and metabolic dysfunction-associated steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.", "fullTimeEmployees": 59, "companyOfficers": [{"maxAge": 1, "name": "Dr. Vipin K. Garg Ph.D.", "age": 66, "title": "President, CEO & Director", "yearBorn": 1958, "fiscalYear": 2023, "totalPay": 986142, "exercisedValue": 0, "unexercisedValue": 4219457}, {"maxAge": 1, "name": "Dr. Matthew Scott Harris AGAF, FCAP, M.D., MS", "age": 71, "title": "Chief Medical Officer", "yearBorn": 1953, "fiscalYear": 2023, "totalPay": 681809, "exercisedValue": 0, "unexercisedValue": 1413049}, {"maxAge": 1, "name": "Mr. Raymond M. Jordt M.B.A.", "age": 51, "title": "Chief Business Officer", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 578850, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gregory L. Weaver CPA, M.B.A.", "age": 68, "title": "Chief Financial Officer", "yearBorn": 1956, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew  Shutterly M.S.", "age": 36, "title": "Principal Financial & Accounting Officer and Corporate Controller", "yearBorn": 1988, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bertrand  Georges Ph.D.", "title": "Chief Technology Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. M. Scot Roberts Ph.D.", "age": 65, "title": "Chief Scientific Officer", "yearBorn": 1959, "fiscalYear": 2023, "totalPay": 599255, "exercisedValue": 0, "unexercisedValue": 565469}, {"maxAge": 1, "name": "Mr. Tony  Blandin B.S.", "title": "Vice President of Quality & Compliance Management", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 4, "compensationRisk": 10, "shareHolderRightsRisk": 4, "overallRisk": 7, "governanceEpochDate": 1738368000, "compensationAsOfEpochDate": 1703980800, "irWebsite": "http://ir.pharmathene.com/phoenix.zhtml?c=191999&p=irol-irhome", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 6.63, "open": 6.72, "dayLow": 6.33, "dayHigh": 6.77, "regularMarketPreviousClose": 6.63, "regularMarketOpen": 6.72, "regularMarketDayLow": 6.33, "regularMarketDayHigh": 6.77, "exDividendDate": 1484870400, "payoutRatio": 0.0, "beta": 0.172, "forwardPE": -4.3435373, "volume": 1255283, "regularMarketVolume": 1255283, "averageVolume": 2577940, "averageVolume10days": 2146510, "averageDailyVolume10Day": 2146510, "bid": 6.38, "ask": 6.42, "bidSize": 1, "askSize": 6, "marketCap": 454130592, "fiftyTwoWeekLow": 5.275, "fiftyTwoWeekHigh": 14.84, "priceToSalesTrailing12Months": 8733.28, "fiftyDayAverage": 7.307, "twoHundredDayAverage": 7.11705, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 333949248, "profitMargins": 0.0, "floatShares": 70456765, "sharesOutstanding": 71124600, "sharesShort": 23319504, "sharesShortPriorMonth": 23693958, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.32790002, "heldPercentInsiders": 0.00821, "heldPercentInstitutions": 0.58146, "shortRatio": 10.27, "shortPercentOfFloat": 0.32880002, "impliedSharesOutstanding": 71124600, "bookValue": 1.875, "priceToBook": 3.4053335, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -103520000, "trailingEps": -1.57, "forwardEps": -1.47, "lastSplitFactor": "1:30", "lastSplitDate": 1536883200, "enterpriseToRevenue": 6422.101, "enterpriseToEbitda": -3.367, "52WeekChange": -0.27934784, "SandP52WeekChange": 0.2021538, "quoteType": "EQUITY", "currentPrice": 6.385, "targetHighPrice": 28.0, "targetLowPrice": 12.0, "targetMeanPrice": 22.25, "targetMedianPrice": 24.5, "recommendationMean": 1.55556, "recommendationKey": "buy", "numberOfAnalystOpinions": 8, "totalCash": 139380000, "totalCashPerShare": 1.96, "ebitda": -99191000, "totalDebt": 1773000, "quickRatio": 16.522, "currentRatio": 16.874, "totalRevenue": 52000, "debtToEquity": 1.329, "revenuePerShare": 0.001, "returnOnAssets": -0.39558998, "returnOnEquity": -0.72959, "grossProfits": -79302000, "freeCashflow": -45628000, "operatingCashflow": -78116000, "revenueGrowth": -0.986, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -4953.4, "financialCurrency": "USD", "symbol": "ALT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchange": "NGM", "messageBoardId": "finmb_4866807", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -3.6953225, "regularMarketPrice": 6.385, "marketState": "REGULAR", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1495805400000, "regularMarketChange": -0.24499989, "regularMarketDayRange": "6.33 - 6.77", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 2577940, "fiftyTwoWeekLowChange": 1.1100001, "fiftyTwoWeekLowChangePercent": 0.21042657, "fiftyTwoWeekRange": "5.275 - 14.84", "fiftyTwoWeekHighChange": -8.455, "fiftyTwoWeekHighChangePercent": -0.56974393, "fiftyTwoWeekChangePercent": -27.934784, "dividendDate": 1536883200, "earningsTimestamp": 1740663000, "earningsTimestampStart": 1740663000, "earningsTimestampEnd": 1740663000, "earningsCallTimestampStart": 1740663000, "earningsCallTimestampEnd": 1740663000, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -1.57, "epsForward": -1.47, "epsCurrentYear": -1.344, "priceEpsCurrentYear": -4.7507443, "fiftyDayAverageChange": -0.92199993, "fiftyDayAverageChangePercent": -0.12618037, "twoHundredDayAverageChange": -0.73204994, "twoHundredDayAverageChangePercent": -0.10285862, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.6 - Buy", "cryptoTradeable": false, "corporateActions": [], "regularMarketTime": 1740170777, "shortName": "Altimmune, Inc.", "longName": "Altimmune, Inc.", "displayName": "Altimmune", "trailingPegRatio": null, "__fetch_time": "2025-02-21"}]